Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance. (2018)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-018-06860-4
PubMed Identifier: 30333494
Publication URI: http://europepmc.org/abstract/MED/30333494
Type: Journal Article/Review
Volume: 9
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723